| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | HQL-79 |
|---|
| Description | Purity >98%. HQL-79 is a selective inhibitor of hematopoietic prostaglandin D (PGD) synthase. Structurally, it is a synthetic tetrazole compound originally prepared as a possible antihistamine. Subsequent evaluation in models of allergy and asthma demonstrates the HQL-79 is orally available, and inhibits the synthesis of PGD2 . HQL-79 is thus a likely lead compound for the preparation of potent, selective hematopoietic PGD synthase inhibitors. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-(diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl]-piperidine |
|---|
| Gene, Accession, CAS # | CAS: 162641-16-9 |
|---|
| Catalog # | LS-H8125 |
|---|
| Price | |
|---|
| Order / More Info | HQL-79 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|